Tocqueville Asset Management L.P. Amgen Inc Transaction History

Tocqueville Asset Management L.P.

$6.27 Billion
Q3 2024

A detailed history of Tocqueville Asset Management L.P. transactions in Amgen Inc stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 20,227 shares of AMGN stock, worth $5.96 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

20,227

Previous 21,427 5.6%

Holding current value

$5.96 Million

Previous $6.69 Million 2.64%

% of portfolio

0.1%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $371,256 - $404,856	-1,200 Reduced 5.6%	20,227 $6.52 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $83,291 - $101,221	-317 Reduced 1.46%	21,427 $6.69 Million
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $15,594 - $18,824	-58 Reduced 0.27%	21,744 $6.18 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $268,229 - $302,594	-1,049 Reduced 4.59%	21,802 $6.28 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $110,418 - $137,087	-505 Reduced 2.16%	22,851 $6.14 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $58,067 - $68,663	-271 Reduced 1.15%	23,356 $5.19 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $31,384 - $38,252	-139 Reduced 0.58%	23,627 $5.71 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $90,695 - $115,239	-396 Reduced 1.64%	23,766 $6.24 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $897,840 - $1.01 Million	-4,000 Reduced 14.2%	24,162 $5.45 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $182,953 - $203,594	-793 Reduced 2.74%	28,162 $6.85 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $119,940 - $132,685	547 Added 1.93%	28,955 $7 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $315,224 - $360,746	-1,585 Reduced 5.28%	28,408 $6.39 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $22,712 - $26,610	-107 Reduced 0.36%	29,993 $6.38 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $24,525 - $27,209	105 Added 0.35%	30,100 $7.34 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $136,252 - $158,780	-614 Reduced 2.01%	29,995 $7.46 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $231,959 - $276,222	-1,072 Reduced 3.38%	30,609 $7.04 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $190,535 - $211,891	-812 Reduced 2.5%	31,681 $8.05 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $490,173 - $601,509	-2,478 Reduced 7.09%	32,493 $7.66 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $845,229 - $1.12 Million	-4,638 Reduced 11.71%	34,971 $7.09 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $7.84 Million - $10.1 Million	-41,421 Reduced 51.12%	39,609 $9.55 Million
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $2.89 Million - $3.47 Million	16,617 Added 25.8%	81,030 $15.7 Million
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $359,405 - $421,303	-2,156 Reduced 3.24%	64,413 $11.9 Million
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $1,989 - $2,242	11 Added 0.02%	66,569 $12.6 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $426,019 - $497,301	2,388 Added 3.72%	66,558 $13 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $5.49 Million - $6.19 Million	-29,652 Reduced 31.6%	64,170 $13.3 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $108,762 - $122,164	-655 Reduced 0.69%	93,822 $17.3 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $2.62 Million - $3.06 Million	15,465 Added 19.57%	94,477 $16.1 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $86,082 - $96,180	510 Added 0.65%	79,012 $13.7 Million
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $13.1 Million - $15 Million	78,502	78,502 $14.6 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account

Tocqueville Asset Management L.P. Amgen Inc Transaction History